Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 8, Issue 2

March-April 2011

In this Issue

Ask the Hematologist
Clinical Trials Corner
Diffusion
Features
In Memoriam
Letters to the Editor
Mini Review
News and Reports
Op Ed
President’s Column
Profiles

Ask the Hematologist

Recommendation of CHOP-Rituximab/More Intensive Regimen Such as Dose-Adjusted EPOCH-Rituximab for Cyclin D1 Expression in DLBCL

John Sweetenham, MD, FRCP

View Articletitled, Recommendation of CHOP-Rituximab/More Intensive Regimen Such as Dose-Adjusted EPOCH-Rituximab for Cyclin D1 Expression in DLBCL

Clinical Trials Corner

Transfusion Independence in MDS Patients Treated with Lenalidomide

David P. Steensma, MD

View Articletitled, Transfusion Independence in MDS Patients Treated with Lenalidomide

Polycythemia Vera

Bart Scott, MD,Michael Linenberger, MD

View Articletitled, Polycythemia Vera

Diffusion

CT Scans in Response and Follow-Up Assessment of CLL: Can We Eliminate Their Use?

John C. Byrd, MD

View Articletitled, CT Scans in Response and Follow-Up Assessment of CLL: Can We Eliminate Their Use?

Antiphospholipid Antibodies Do NO Wrong

Robert Flaumenhaft, MD, PhD

View Articletitled, Antiphospholipid Antibodies Do NO Wrong

The Flavors of MPNs: Is STAT1 the Key Ingredient?

Jason Gotlib, MD, MS

View Articletitled, The Flavors of MPNs: Is STAT1 the Key Ingredient?

Is There a Path to Quality of Life for Elderly Patients Treated for Myeloma?

Xavier Leleu, MD, PhD

View Articletitled, Is There a Path to Quality of Life for Elderly Patients Treated for Myeloma?

Not Too Little, Not Too Much, Just the Right Amount of Hepcidin Can Limit Iron Overload in β-Thalassemic Mice

Gregory M. Vercellotti, MD

View Articletitled, Not Too Little, Not Too Much, Just the Right Amount of Hepcidin Can Limit Iron Overload in β-Thalassemic Mice

Turning Over the Rotting Log in Del(5q) Myelodysplasia

David P. Steensma, MD

View Articletitled, Turning Over the Rotting Log in Del(5q) Myelodysplasia

Gene Therapy for Wiskott-Aldrich Syndrome: Benefits and Risks

Diane Krause, MD, PhD

View Articletitled, Gene Therapy for Wiskott-Aldrich Syndrome: Benefits and Risks

Clinical Anti-Myeloma Activity of Aminobisphosphonates

Kenneth C. Anderson, MD

View Articletitled, Clinical Anti-Myeloma Activity of Aminobisphosphonates

Take This One for a Test Drive: It Looks Like a HIT

Margaret V. Ragni, MD, MPH

View Articletitled, Take This One for a Test Drive: It Looks Like a HIT

Membrane Phospholipid Scrambling by TMEM16F

Pete Lollar, MD

View Articletitled, Membrane Phospholipid Scrambling by TMEM16F

A Role for TET2 Dysregulation in Myeloid Malignancies

Steven Grant, MD

View Articletitled, A Role for TET2 Dysregulation in Myeloid Malignancies

Features

Enhancing Research in Regenerative Medicine

David A. Williams, MD,Armand Keating, MD

View Articletitled, Enhancing Research in Regenerative Medicine

In Memoriam

Eugene Goldwasser 1922 – 2010

ASH Staff

View Articletitled, Eugene Goldwasser 1922 – 2010

Letters to the Editor

Letter to the Editor

View Articletitled, Letter to the Editor

Mini Review

Dabigatran: An Important New Option for Chronic Anticoagulation

Lawrence Leung, MD

View Articletitled, Dabigatran: An Important New Option for Chronic Anticoagulation

News and Reports

ASH Program Successful in Promoting Minority Careers

Michael DeBaun, MD, MPH

View Articletitled, ASH Program Successful in Promoting Minority Careers

Op Ed

The Perpetual Fellow — Extending Fellowship Training in Hematology: The Trainee Perspective

Jennifer Woyach, MD,Martin Palmeri, MD,Kevin Kuo, MD

View Articletitled, The Perpetual Fellow — Extending Fellowship Training in Hematology: The Trainee Perspective

President’s Column

President’s Column: Restoring Clinical and Translational Research

J. Evan Sadler, MD, PhD

View Articletitled, President’s Column: Restoring Clinical and Translational Research

Profiles

The ASH Scholar Award: Just the Beginning

David Motto, MD, PhD

View Articletitled, The ASH Scholar Award: Just the Beginning

Cover Image

Cover Image

All Issues

Advertisement intended for health care professionals

Email alerts

Latest Issue Alert

Continuous Publishing Alert

New Journal Content Alert

Latest
Most Read

Vitamin A to Keep GVHD Away: Single Oral High-Dose Vitamin A Before Bone Marrow Transplant Reduces Graft-Versus-Host Disease in Pediatric and Young Adult Patients

Trainee Corner
A Career in Academia: Should I Stay or Should I Go?

Then and Now
Treatment for Acute Leukemia in Older Adults: Two Decades of Remarkable Progress

Does Sustained Monocytosis Always Mean CMML? A Case of Ras-Associated Autoimmune Leukoproliferative Disorder

ASH and Federal Officials Hold Town Hall on Sickle Cell Disease

Advertisement intended for health care professionals

Table of Contents

Ask the Hematologist

Recommendation of CHOP-Rituximab/More Intensive Regimen Such as Dose-Adjusted EPOCH-Rituximab for Cyclin D1 Expression in DLBCL

Clinical Trials Corner

Transfusion Independence in MDS Patients Treated with Lenalidomide

Polycythemia Vera

Diffusion

CT Scans in Response and Follow-Up Assessment of CLL: Can We Eliminate Their Use?

Antiphospholipid Antibodies Do NO Wrong

The Flavors of MPNs: Is STAT1 the Key Ingredient?

Is There a Path to Quality of Life for Elderly Patients Treated for Myeloma?

Not Too Little, Not Too Much, Just the Right Amount of Hepcidin Can Limit Iron Overload in β-Thalassemic Mice

Turning Over the Rotting Log in Del(5q) Myelodysplasia

Gene Therapy for Wiskott-Aldrich Syndrome: Benefits and Risks

Clinical Anti-Myeloma Activity of Aminobisphosphonates

Take This One for a Test Drive: It Looks Like a HIT

Membrane Phospholipid Scrambling by TMEM16F

A Role for TET2 Dysregulation in Myeloid Malignancies

Features

Enhancing Research in Regenerative Medicine

In Memoriam

Eugene Goldwasser 1922 – 2010

Letters to the Editor

Letter to the Editor

Mini Review

Dabigatran: An Important New Option for Chronic Anticoagulation

News and Reports

ASH Program Successful in Promoting Minority Careers

Op Ed

The Perpetual Fellow — Extending Fellowship Training in Hematology: The Trainee Perspective

President’s Column

President’s Column: Restoring Clinical and Translational Research

Profiles

The ASH Scholar Award: Just the Beginning

Email alerts

ASH Publications

American Society of Hematology

Issue Archive

Table of Contents

Ask the Hematologist

Clinical Trials Corner

Diffusion

Features

In Memoriam

Letters to the Editor

Mini Review

News and Reports

Op Ed

President’s Column

Profiles

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only